Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients

doi:10.3748/wjg.v21.i36.10443

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8611)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

529

WORD

287

HTML

4910

Figures (1-3)

220

Tables (1-4)

164

Sum=6110

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1049

Download

1452

Sum=2501

Sep 28, 2015 (publication date) through Sep 5, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Sep 28, 2015; 21(36): 10443-10452
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10443

Full Size Figure Download Figure

Figure 1 Flow chart of the treatment scheme. PFS: Progression free survival; ORR: Objective response rate; DCR: Disease control rate; HAIC: Hepatic arterial infusion chemotherapy; PVA: Polyvinyl alcohol particles; BCLC: Barcelona Clinic Liver Cancer staging.

Citation: Gao S, Zhang PJ, Guo JH, Chen H, Xu HF, Liu P, Yang RJ, Zhu X. Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients. World J Gastroenterol 2015; 21(36): 10443-10452
URL: https://www.wjgnet.com/1007-9327/full/v21/i36/10443.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i36.10443